Literature DB >> 29166586

The Broad Spectrum of Human Natural Killer Cell Diversity.

Aharon G Freud1, Bethany L Mundy-Bosse2, Jianhua Yu2, Michael A Caligiuri3.   

Abstract

Natural killer (NK) cells provide protection against infectious pathogens and cancer. For decades it has been appreciated that two major NK cell subsets (CD56bright and CD56dim) exist in humans and have distinct anatomical localization patterns, phenotypes, and functions in immunity. In light of this traditional NK cell dichotomy, it is now clear that the spectrum of human NK cell diversity is much broader than originally appreciated as a result of variegated surface receptor, intracellular signaling molecule, and transcription factor expression; tissue-specific imprinting; and foreign antigen exposure. The recent discoveries of tissue-resident NK cell developmental intermediates, non-NK innate lymphoid cells, and the capacity for NK cells to adapt and differentiate into long-lived memory cells has added further complexity to this field. Here we review our current understanding of the breadth and generation of human NK cell diversity.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 29166586      PMCID: PMC5728700          DOI: 10.1016/j.immuni.2017.10.008

Source DB:  PubMed          Journal:  Immunity        ISSN: 1074-7613            Impact factor:   31.745


  144 in total

1.  Analysis of T-cell receptor gene rearrangement and expression in human natural killer clones.

Authors:  J Ritz; T J Campen; R E Schmidt; H D Royer; T Hercend; R E Hussey; E L Reinherz
Journal:  Science       Date:  1985-06-28       Impact factor: 47.728

2.  CD56bright natural killer cells are present in human lymph nodes and are activated by T cell-derived IL-2: a potential new link between adaptive and innate immunity.

Authors:  Todd A Fehniger; Megan A Cooper; Gerard J Nuovo; Marina Cella; Fabio Facchetti; Marco Colonna; Michael A Caligiuri
Journal:  Blood       Date:  2002-12-12       Impact factor: 22.113

3.  Cutting edge: NKG2C(hi)CD57+ NK cells respond specifically to acute infection with cytomegalovirus and not Epstein-Barr virus.

Authors:  Deborah W Hendricks; Henry H Balfour; Samantha K Dunmire; David O Schmeling; Kristin A Hogquist; Lewis L Lanier
Journal:  J Immunol       Date:  2014-04-16       Impact factor: 5.422

4.  A distinct subpopulation of human NK cells restricts B cell transformation by EBV.

Authors:  Anna Lünemann; Liliana D Vanoaica; Tarik Azzi; David Nadal; Christian Münz
Journal:  J Immunol       Date:  2013-10-09       Impact factor: 5.422

Review 5.  Natural killer cell alloreactivity 10 years later.

Authors:  Andrea Velardi
Journal:  Curr Opin Hematol       Date:  2012-11       Impact factor: 3.284

6.  Cutting Edge: Human CD49e- NK Cells Are Tissue Resident in the Liver.

Authors:  Han Xian Aw Yeang; Sytse J Piersma; Yiing Lin; Liping Yang; Olga N Malkova; Cathrine Miner; Alexander S Krupnick; William C Chapman; Wayne M Yokoyama
Journal:  J Immunol       Date:  2017-01-16       Impact factor: 5.422

7.  Critical role for the chemokine receptor CXCR6 in NK cell-mediated antigen-specific memory of haptens and viruses.

Authors:  Silke Paust; Harvinder S Gill; Bao-Zhong Wang; Michael P Flynn; E Ashley Moseman; Balimkiz Senman; Marian Szczepanik; Amalio Telenti; Philip W Askenase; Richard W Compans; Ulrich H von Andrian
Journal:  Nat Immunol       Date:  2010-10-24       Impact factor: 25.606

8.  'Emergency exit' of bone-marrow-resident CD34(+)DNAM-1(bright)CXCR4(+)-committed lymphoid precursors during chronic infection and inflammation.

Authors:  Federica Bozzano; Francesco Marras; Maria Libera Ascierto; Claudia Cantoni; Giovanni Cenderello; Chiara Dentone; Antonio Di Biagio; Giancarlo Orofino; Eugenio Mantia; Silvia Boni; Pasqualina De Leo; Antonino Picciotto; Fulvio Braido; Francesca Antonini; Ena Wang; Francesco Marincola; Lorenzo Moretta; Andrea De Maria
Journal:  Nat Commun       Date:  2015-10-05       Impact factor: 14.919

9.  Antigen-specific expansion and differentiation of natural killer cells by alloantigen stimulation.

Authors:  Tsukasa Nabekura; Lewis L Lanier
Journal:  J Exp Med       Date:  2014-11-03       Impact factor: 14.307

10.  CXCR6 marks a novel subset of T-bet(lo)Eomes(hi) natural killer cells residing in human liver.

Authors:  Kerstin A Stegmann; Francis Robertson; Navjyot Hansi; Upkar Gill; Celeste Pallant; Theodoros Christophides; Laura J Pallett; Dimitra Peppa; Claire Dunn; Giuseppe Fusai; Victoria Male; Brian R Davidson; Patrick Kennedy; Mala K Maini
Journal:  Sci Rep       Date:  2016-05-23       Impact factor: 4.379

View more
  201 in total

1.  Differential effects of BTK inhibitors ibrutinib and zanubrutinib on NK-cell effector function in patients with mantle cell lymphoma.

Authors:  Thijs W H Flinsenberg; Charnelle C Tromedjo; Nan Hu; Ye Liu; Yin Guo; Kevin Y T Thia; Tahereh Noori; Xiaomin Song; Han X Aw Yeang; Daniela G Tantalo; Sasanka Handunnetti; John F Seymour; Andrew W Roberts; David Ritchie; Rachel Koldej; Paul J Neeson; Lai Wang; Joseph A Trapani; Constantine S Tam; Ilia Voskoboinik
Journal:  Haematologica       Date:  2020-01-31       Impact factor: 9.941

Review 2.  Innate Lymphoid Cells: Diversity, Plasticity, and Unique Functions in Immunity.

Authors:  Marco Colonna
Journal:  Immunity       Date:  2018-06-19       Impact factor: 31.745

Review 3.  Emerging insights into human health and NK cell biology from the study of NK cell deficiencies.

Authors:  Emily M Mace; Jordan S Orange
Journal:  Immunol Rev       Date:  2019-01       Impact factor: 12.988

Review 4.  Killers 2.0: NK cell therapies at the forefront of cancer control.

Authors:  Jonathan J Hodgins; Sarwat T Khan; Maria M Park; Rebecca C Auer; Michele Ardolino
Journal:  J Clin Invest       Date:  2019-09-03       Impact factor: 14.808

5.  Diversity of peripheral blood human NK cells identified by single-cell RNA sequencing.

Authors:  Samantha L Smith; Philippa R Kennedy; Kevin B Stacey; Jonathan D Worboys; Annie Yarwood; Seungmae Seo; Everardo Hegewisch Solloa; Brandon Mistretta; Sujash S Chatterjee; Preethi Gunaratne; Kimaada Allette; Ying-Chih Wang; Melissa Laird Smith; Robert Sebra; Emily M Mace; Amir Horowitz; Wendy Thomson; Paul Martin; Steve Eyre; Daniel M Davis
Journal:  Blood Adv       Date:  2020-04-14

Review 6.  Defining the role of NK cells during dengue virus infection.

Authors:  Anuja Mathew
Journal:  Immunology       Date:  2018-03-23       Impact factor: 7.397

7.  High-parametric evaluation of human invariant natural killer T cells to delineate heterogeneity in allo- and autoimmunity.

Authors:  Tom Erkers; Bryan J Xie; Laura J Kenyon; Brian Smith; Mary Rieck; Kent P Jensen; Xuhuai Ji; Marina Basina; Samuel Strober; Robert S Negrin; Holden T Maecker; Everett H Meyer
Journal:  Blood       Date:  2020-03-12       Impact factor: 22.113

8.  Different Selected Mechanisms Attenuated the Inhibitory Interaction of KIR2DL1 with C2+ HLA-C in Two Indigenous Human Populations in Southern Africa.

Authors:  Neda Nemat-Gorgani; Hugo G Hilton; Brenna M Henn; Meng Lin; Christopher R Gignoux; Justin W Myrick; Cedric J Werely; Julie M Granka; Marlo Möller; Eileen G Hoal; Makoto Yawata; Nobuyo Yawata; Lies Boelen; Becca Asquith; Peter Parham; Paul J Norman
Journal:  J Immunol       Date:  2018-03-16       Impact factor: 5.422

Review 9.  Herpesvirus Evasion of Natural Killer Cells.

Authors:  Steffi De Pelsmaeker; Nicolas Romero; Massimo Vitale; Herman W Favoreel
Journal:  J Virol       Date:  2018-05-14       Impact factor: 5.103

10.  Human innate lymphoid cell precursors express CD48 that modulates ILC differentiation through 2B4 signaling.

Authors:  Dejene M Tufa; Ashley M Yingst; George Devon Trahan; Tyler Shank; Dallas Jones; Seonhui Shim; Jessica Lake; Kevin Winkler; Laura Cobb; Renee Woods; Kenneth Jones; Michael R Verneris
Journal:  Sci Immunol       Date:  2020-11-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.